相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis
Yahui Grace Chiu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
LOX Fails to Substitute for RANKL in Osteoclastogenesis
Masayuki Tsukasaki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα
Seyeon Bae et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation
Lynett Danks et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The role of osteoclast differentiation and function in skeletal homeostasis
Kyoji Ikeda et al.
JOURNAL OF BIOCHEMISTRY (2016)
Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression
Min Joon Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects
Wei Wei et al.
CELL METABOLISM (2016)
VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone
Ricardo Usategui-Martin et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
Jian Luo et al.
NATURE MEDICINE (2016)
RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis
William O'Brien et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms
Rong Zeng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Thomas R. Cox et al.
NATURE (2015)
DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway
Keizo Nishikawa et al.
NATURE MEDICINE (2015)
Immune complexes regulate bone metabolism through FcRγ signalling
Takako Negishi-Koga et al.
NATURE COMMUNICATIONS (2015)
Mitochondrial Complex I Activity Suppresses Inflammation and Enhances Bone Resorption by Shifting Macrophage-Osteoclast Polarization
Zixue Jin et al.
CELL METABOLISM (2014)
Combination of Tumor Necrosis Factor α and Interleukin-6 Induces Mouse Osteoclast-like Cells With Bone Resorption Activity Both In Vitro and In Vivo
Kazuhiro Yokota et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis
Han Kyoung Choi et al.
CELL RESEARCH (2013)
Metabolic Regulation of Osteoclast Differentiation and Function
Yoriko Indo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Osteopetrosis: genetics, treatment and new insights into osteoclast function
Cristina Sobacchi et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis
H. S. Kim et al.
CELLULAR SIGNALLING (2012)
TREM2 and β-Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis
Karel Otero et al.
JOURNAL OF IMMUNOLOGY (2012)
Osteoprotection by semaphorin 3A
Mikihito Hayashi et al.
NATURE (2012)
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab
David L. Lacey et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Georg Schett et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8
Lionel B. Ivashkiv et al.
SKELETAL BIOLOGY AND MEDICINE I (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
Wei Wei et al.
CELL METABOLISM (2010)
Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab
K. A. Toulis et al.
OSTEOPOROSIS INTERNATIONAL (2010)
PPARγ in bone homeostasis
Yihong Wan
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-κB Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression
Kyung-Hyun Park-Min et al.
JOURNAL OF IMMUNOLOGY (2009)
Inhibition of RANK Expression and Osteoclastogenesis by TLRs and IFN-γ in Human Osteoclast Precursors
Jong-Dae Ji et al.
JOURNAL OF IMMUNOLOGY (2009)
Central control of fever and female body temperature by RANKL/RANK
Reiko Hanada et al.
NATURE (2009)
Coordination of PGC-1 beta and iron uptake in mitochondrial biogenesis and osteoclast activation
Kiyo-aki Ishii et al.
NATURE MEDICINE (2009)
Chloride channels as drug targets
Alan S. Verkman et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The osteoclast: Friend or foe?
Deborah V. Novack et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2008)
Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals
Masahiro Shinohara et al.
CELL (2008)
Osteoimmunology: Interactions of the bone and immune system
Joseph Lorenzo et al.
ENDOCRINE REVIEWS (2008)
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism
Antonios O. Aliprantis et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk
Wei Zou et al.
MOLECULAR CELL (2008)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2
Dailing Mao et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-κB transactivation by RANKL
H. Huang et al.
CELL DEATH AND DIFFERENTIATION (2006)
Regulation of osteoclast function and bone mass by RAGE
Z Zhou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function
MB Humphrey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system
S Tanaka et al.
IMMUNOLOGICAL REVIEWS (2005)
M-CSF mediates TNF-induced inflammatory osteolysis
H Kitaura et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis
N Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis
T Wada et al.
NATURE MEDICINE (2005)
Vav3 regulates osteoclast function and bone mass
R Faccio et al.
NATURE MEDICINE (2005)
The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase
A Mócsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
T Koga et al.
NATURE (2004)
TCIRG1-dependent recessive osteopetrosis: Mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA
L Susani et al.
HUMAN MUTATION (2004)
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis
A Frattini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
J Paloneva et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
H Takayanagi et al.
NATURE (2002)
Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6
J Mizukami et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
H Takayanagi et al.
NATURE (2000)
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
JE Fata et al.
CELL (2000)
Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts
Y Azuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
J Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
K Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
